Related Experiment Video
Updated: Aug 29, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair
Greg Stratmann1, Isobel A Russell, Scott H Merrick
1Department of Anesthesia and Perioperative Care, University of California at San Francisco, San Francisco, California 94143, USA. gstratmann@anesthesia.ucsf.edu
Hemorrhage, refractory to aggressive conventional therapy, at a rate of 16 L/hr following separation from cardiopulmonary bypass for aortic arch repair, was controlled with a dose of 90 microg/kg of recombinant factor VIIa, repeated once after 2 hours.
Hemorrhage, refractory to aggressive conventional therapy, at a rate of 16 L/hr following separation from cardiopulmonary bypass for aortic arch repair, was controlled with a dose of 90 microg/kg of recombinant factor VIIa, repeated once after 2 hours.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis
Aneurysm III: Interprofessional Care
